Evidence map›Paper›PMID 31941729›Full record

ReviewClinical medicine (London, England)2020

Infective endocarditis: A contemporary update.

Ronak Rajani, John L Klein

Registry-linked trialAbstract readReview
In one paragraph

Review in Clinical medicine (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06266741 (The Predictive Value of Lubricin in Patients With Infective Endocarditis), which is not on this map. Cited by 162 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06266741 unknown statusnot on this mapstarted 2024, after this paper: background citation

The Predictive Value of Lubricin in Patients With Infective Endocarditis

TypeobservationalSponsorAydin Adnan Menderes UniversityRan2024 to 2026Enrolled60ConditionsInfective EndocarditisArmsLubricin
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Infective Endocarditis byPathogens (Basel, Switzerland) · 2025
    Pooled it
  3. Frontiers in medicine · 2024
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Role ofBiomedicines · 2026
    Review
  18. Article
  19. Review
  20. Review

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ronak RajaniGuy's and St Thomas' NHS Foundation Trust, London, UK ronak.rajani@gstt.nhs.uk.
John L KleinGuy's and St Thomas' NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infective endocarditis (IE) remains a rare condition but one with high associated morbidity and mortality. With an ageing population and increasing use of implantable cardiac devices and heart valves, the epidemiology of IE has changed. Early clinical suspicion and a rapid diagnosis are essential to enable the correct treatment pathways to be accessed and to reduce complication and mortality rates. In the current review, we detail the latest guidelines for the evaluation and management of patients with endocarditis and its prevention.

Indexed as

EndocarditisEndocarditis, BacterialAnti-Bacterial AgentsHumansAnti-Bacterial Agentsantibiotic prophylaxisdiagnosisendocarditis teamInfective endocarditissurgical indications

Identifiers

PMID31941729
PMCPMC6964163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.